77
40
Growth Score 77 in past quarter
-9 pts
Heat Score 40 in past quarter
-16 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
4167603
Microlin Bio, Inc., a development stage biopharmaceutical company.
About the Company
Microlin Bio, Inc., a development stage biopharmaceutical company, focuses on identifying and developing pharmaceutical and diagnostic products for the diagnosis and treatment of cancer. It intends to develop a series of diagnostic microRNA panel tests, and miR-based antimicroRNA therapy and microRNA-replacement therapy agents for lung, ovarian,
colorectal, and prostate cancers. The company was founded in 2013 and is headquartered New York, New York.